• Markets
  • icon
  • Companies
TRP · ASX

Tissue Repair Ltd (ASX:TRP)

AU$0.22

 0.0 (0.0%)
ASX:Live
22/05/2024 03:31:05 PM
HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

TRP Overview

TRP Health Scores

Short Term

Mean Revision

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Strong

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About TRP

Website

N/A

Telephone

N/A

Address

Description

Tissue Repair Ltd. is a clinical stage bio pharmaceutical company, which develops advanced wound healing products targeting applications in the chronic wound and aesthetic procedure aftercare markets, with the potential for further development of related technologies. The company has developed an ingredient that is designed for wound healing and the biologically active pharmaceutical ingredient behaves like a decoy cell that simulates a yeast infection, resulting in the stimulation of the body's own wound repair pathways. The company was founded by Tony Charara in 2012 and is headquartered in Sydney, Australia.

TRP Price Chart

Key Stats

Market Cap

AU$13.30M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.21 - 0.35

Trade Value (12mth)

AU$2,132.00

1 week

0%

1 month

-8.33%

YTD

0%

1 year

-15.38%

All time high

0.8299999833106995

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

%

Operating Cashflow

-$4m

Free Cash Flow Return

-18.00%

ROIC

-17.70%

Interest Coverage

N/A

Quick Ratio

45.60

Other Data

Shares on Issue (Fully Dilluted)

60m

HALO Sector

Next Company Report Date

28-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

TRP Announcements

Latest Announcements

Date Announcements

15 May 24

Application for quotation of securities - TRP

×

Application for quotation of securities - TRP

09 May 24

Notice under ASX Listing Rule 3.10A

×

Notice under ASX Listing Rule 3.10A

30 April 24

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

04 April 24

Notification regarding unquoted securities - TRP

×

Notification regarding unquoted securities - TRP

01 March 24

Change of Company Secretary

×

Change of Company Secretary

29 February 24

Appendix 4D and Half Year Report to 31 December 2023

×

Appendix 4D and Half Year Report to 31 December 2023

30 January 24

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

19 December 23

Third US Patent granted for Tissue Repair Glucoprime

×

Third US Patent granted for Tissue Repair Glucoprime

20 November 23

Application for quotation of securities - TRP

×

Application for quotation of securities - TRP

16 November 23

Change of Director's Interest Notice - Michael Silberberg

×

Change of Director's Interest Notice - Michael Silberberg

15 November 23

Notification regarding unquoted securities - TRP

×

Notification regarding unquoted securities - TRP

09 November 23

Notice under ASX Listing Rule 3.10A

×

Notice under ASX Listing Rule 3.10A

30 October 23

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

26 October 23

AGM Presentation

×

AGM Presentation

26 October 23

Results of Meeting

×

Results of Meeting

22 September 23

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

18 September 23

Company Update - Presentation

×

Company Update - Presentation

31 August 23

Appendix 4E and Annual Report 30 June 2023

×

Appendix 4E and Annual Report 30 June 2023

31 August 23

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

31 July 23

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

28 June 23

Change of Company Secretary

×

Change of Company Secretary

06 June 23

Change of Director's Interest Notice - JL

×

Change of Director's Interest Notice - JL

29 May 23

FDA clears TR-987 to progress to Phase 3

×

FDA clears TR-987 to progress to Phase 3

17 May 23

Notification of cessation of securities - TRP

×

Notification of cessation of securities - TRP

02 May 23

Initial Director's Interest Notice - MS

×

Initial Director's Interest Notice - MS

TRP Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock N/A N/A -0.07 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock N/A N/A -0.07 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock N/A N/A -0.06 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock N/A N/A -0.07 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A -26.1 Lock Lock Lock
DPS $ Lock Lock Lock Lock N/A N/A 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock N/A N/A 0.36 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock N/A N/A 0.36 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock N/A N/A 60 Lock Lock Lock
Basic m Lock Lock Lock Lock N/A N/A 60 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock N/A N/A 6 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A 13.9 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock N/A N/A 86 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock N/A N/A -6 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A -186,530.6 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock N/A N/A -6 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A -186,616.7 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock N/A N/A -5 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock N/A N/A -1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock N/A N/A -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A -135,709.2 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock N/A N/A -4 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock N/A N/A -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A -1,384.2 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock N/A N/A 21 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock N/A N/A 22 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock N/A N/A -21 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Equity $m Lock Lock Lock Lock N/A N/A 22 Lock Lock Lock
Invested Capital Lock Lock Lock Lock N/A N/A 22 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock N/A N/A -18.7 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock N/A N/A -19.1 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock N/A N/A -24.3 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock N/A N/A -17.7 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock N/A N/A -18.0 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock N/A N/A 3.7 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock N/A N/A -97.8 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock N/A N/A 45.6 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock N/A N/A 45.6 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock N/A N/A 95.6 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock N/A N/A -867.1 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A N/A 0.3 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock N/A N/A 2,675.5 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock N/A N/A -167,197.4 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock N/A N/A -23.0 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock N/A N/A -18.7 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock N/A N/A 1.0 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock N/A N/A -19.1 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock N/A N/A 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock N/A N/A -19.1 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A N/A 1,398.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock N/A N/A 71,631.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock N/A N/A 73,029.1 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock N/A N/A 2,214.8 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock N/A N/A 70,814.2 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

TRP Shortsell

Frequently Asked Questions

The current share price of Tissue Repair Ltd (TRP:ASX) is AU$0.22.
The 52-week high share price for Tissue Repair Ltd (TRP:ASX) is AU$0.35.
The 52-week low share price for Tissue Repair Ltd (TRP:ASX)? is AU$0.21.
Tissue Repair Ltd (TRP:ASX) does not pay a dividend.
Tissue Repair Ltd (TRP:ASX) does not pay a dividend.
Tissue Repair Ltd (TRP:ASX) has a franking level of 0.0%.
Tissue Repair Ltd (TRP:ASX) is classified in the Healthcare.
The current P/E ratio for Tissue Repair Ltd (TRP:ASX) is .